Agili-C

País: Israel

Idioma: hebreo

Fuente: Ministry of Health

Disponible desde:

Cartiheal (2009) Ltd.

clase:

בית חולים

Fabricado por:

Cartiheal (2009) Ltd.

Grupo terapéutico:

רופא

indicaciones terapéuticas:

Agili-C implant is a bi-phasic, porous resorbable tissue regeneration scaffold for the treatment of focal articular cartilage and/or osteochondral defects. It is indicated for cartilage and/or bone repair. The implant serves as a scaffold for cellular and matrix ingrowth. The Agili-C implant is expected to biodegrade within 6 – 12 months.

Resumen del producto:

Agili-C implant is a bi-phasic, porous resorbable tissue regeneration scaffold for the treatment of focal articular cartilage and/or osteochondral defects. It is indicated for cartilage and/or bone repair. The implant serves as a scaffold for cellular and matrix ingrowth. The Agili-C implant is expected to biodegrade within 6 – 12 months.